PVLA
Palvella Therapeutics
PVLA
PVLA
49 hedge funds and large institutions have $114M invested in Palvella Therapeutics in 2017 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.09% more ownership
Funds ownership: 0.56% → 0.65% (+0.09%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
49
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.97M | |
| 2 | +$7.07M | |
| 3 | +$4.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.38M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.63M |
Top Sellers
| 1 | -$5.77M | |
| 2 | -$5.58M | |
| 3 | -$1.67M | |
| 4 |
Renaissance Technologies
New York
|
-$700K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$139K |